High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-07

AUTHORS

K. Kanai, M. Kako, T. Kumada, H. Tsubouchi, T. Aikawa, M. Kojima, H. Harada, T. Kawasaki, M. Nakashima, H. Okamoto, S. Mishiro

ABSTRACT

Efficacy of standard regimens (e.g., 3-6 MU for 24 weeks) of alfa-IFN therapy for chronic hepatitis C has been limited, particularly in patients with HCV/1b. To see if higher-dose longer term treatment is more effective, we tried a 9 MU 60-week regimen. HCV/1b-infected chronic hepatitis patients received 9 MU IFN alpha 2a everyday but Sunday for 2 weeks and thrice a week for next 10 weeks, and 76 patients became HCV RNA-negative while 81 remained positive. The RNA-negative patients were then randomized to receive 3 MU (group I, n = 37) or 9 MU (group II, n = 39) for 48 weeks. Of the RNA-positive patients, only those with normal ALT received another 9 MU 48-week treatment (group III, n = 45). Sustained responders (SR) were defined as those with negative RNA and normal ALT 6 months after the therapy. SR rates based on intent-to-treat principle did not differ significantly between groups I and II (30% vs 41%), but those based on the protocol-compatible cases showed a significantly lower than those in group II. Adverse effects of IFN, developed more frequently in groups II and III than in group I, were mostly reversible. In conclusion, our results encourage 9 MU 60-week IFN alpha treatment in HCV/1b-infected patients with careful attention to adverse effects, and suggest that the treatment should be discontinued if HCV RNA does not disappear within 12 weeks. More... »

PAGES

1545-1554

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s007050050397

DOI

http://dx.doi.org/10.1007/s007050050397

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034445880

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9739333


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepacivirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hepatitis C, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-alpha", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Recombinant Proteins", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Toshiba General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417200.0", 
          "name": [
            "Department of Gastroenterology, Toshiba General Hospital, Tokyo, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanai", 
        "givenName": "K.", 
        "id": "sg:person.01330017252.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330017252.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Teikyo University", 
          "id": "https://www.grid.ac/institutes/grid.264706.1", 
          "name": [
            "The Fourth Department of Medicine, Teikyo University School of Medicine, Mizonokuchi Hospital, Kanagawa, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kako", 
        "givenName": "M.", 
        "id": "sg:person.01022667506.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022667506.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ogaki Municipal Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416762.0", 
          "name": [
            "Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kumada", 
        "givenName": "T.", 
        "id": "sg:person.0770416306.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770416306.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Miyazaki", 
          "id": "https://www.grid.ac/institutes/grid.410849.0", 
          "name": [
            "The Second Department of Medicine, Miyazaki Medical College, Miyazaki, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsubouchi", 
        "givenName": "H.", 
        "id": "sg:person.01106573463.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106573463.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Aikawa Internal Hospital, Ibaraki, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aikawa", 
        "givenName": "T.", 
        "id": "sg:person.01261704052.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261704052.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Medicine, Kojima Internal Clinic, Gifu, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kojima", 
        "givenName": "M.", 
        "id": "sg:person.011276771725.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011276771725.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo National Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417136.6", 
          "name": [
            "Department of Medicine, Tokyo National Chest Hospital, Tokyo, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Harada", 
        "givenName": "H.", 
        "id": "sg:person.011764702202.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011764702202.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hamamatsu University", 
          "id": "https://www.grid.ac/institutes/grid.411951.9", 
          "name": [
            "The Second Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kawasaki", 
        "givenName": "T.", 
        "id": "sg:person.01001517660.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001517660.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hamamatsu University", 
          "id": "https://www.grid.ac/institutes/grid.411951.9", 
          "name": [
            "Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakashima", 
        "givenName": "M.", 
        "id": "sg:person.01055662424.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055662424.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jichi Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Immunology Division, Jichi Medical School, Tochigi, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okamoto", 
        "givenName": "H.", 
        "id": "sg:person.0674453736.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674453736.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Toshiba General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417200.0", 
          "name": [
            "Department of Medical Sciences, Toshiba General Hospital, Tokyo, Japan, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mishiro", 
        "givenName": "S.", 
        "id": "sg:person.013711476524.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013711476524.52"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-07", 
    "datePublishedReg": "1998-07-01", 
    "description": "Efficacy of standard regimens (e.g., 3-6 MU for 24 weeks) of alfa-IFN therapy for chronic hepatitis C has been limited, particularly in patients with HCV/1b. To see if higher-dose longer term treatment is more effective, we tried a 9 MU 60-week regimen. HCV/1b-infected chronic hepatitis patients received 9 MU IFN alpha 2a everyday but Sunday for 2 weeks and thrice a week for next 10 weeks, and 76 patients became HCV RNA-negative while 81 remained positive. The RNA-negative patients were then randomized to receive 3 MU (group I, n = 37) or 9 MU (group II, n = 39) for 48 weeks. Of the RNA-positive patients, only those with normal ALT received another 9 MU 48-week treatment (group III, n = 45). Sustained responders (SR) were defined as those with negative RNA and normal ALT 6 months after the therapy. SR rates based on intent-to-treat principle did not differ significantly between groups I and II (30% vs 41%), but those based on the protocol-compatible cases showed a significantly lower than those in group II. Adverse effects of IFN, developed more frequently in groups II and III than in group I, were mostly reversible. In conclusion, our results encourage 9 MU 60-week IFN alpha treatment in HCV/1b-infected patients with careful attention to adverse effects, and suggest that the treatment should be discontinued if HCV RNA does not disappear within 12 weeks.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s007050050397", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1083335", 
        "issn": [
          "0304-8608", 
          "1432-8798"
        ], 
        "name": "Archives of Virology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "143"
      }
    ], 
    "name": "High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b", 
    "pagination": "1545-1554", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a41617b0d107430aefb554723cb452d58c0cf58ade50634fca97647d61a55210"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9739333"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7506870"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s007050050397"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034445880"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s007050050397", 
      "https://app.dimensions.ai/details/publication/pub.1034445880"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000482.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s007050050397"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s007050050397'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s007050050397'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s007050050397'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s007050050397'


 

This table displays all metadata directly associated to this object as RDF triples.

187 TRIPLES      20 PREDICATES      35 URIs      27 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s007050050397 schema:about N03a81c8441214ab6bde8ceafceda7ebe
2 N2917f37751a64fb5bd5a18cab534bb61
3 N3abfa2db44044c80ab52d3ab08e81e1f
4 Nbb41b7c54b484ef089d3e59f00ac9231
5 Nd99505f363294c8eb0c47e7b472bcedd
6 Nfb94f82b1e464e88ab072f6390624cf2
7 anzsrc-for:11
8 anzsrc-for:1103
9 schema:author N7f2eeea7520248da808e7f46348424d9
10 schema:datePublished 1998-07
11 schema:datePublishedReg 1998-07-01
12 schema:description Efficacy of standard regimens (e.g., 3-6 MU for 24 weeks) of alfa-IFN therapy for chronic hepatitis C has been limited, particularly in patients with HCV/1b. To see if higher-dose longer term treatment is more effective, we tried a 9 MU 60-week regimen. HCV/1b-infected chronic hepatitis patients received 9 MU IFN alpha 2a everyday but Sunday for 2 weeks and thrice a week for next 10 weeks, and 76 patients became HCV RNA-negative while 81 remained positive. The RNA-negative patients were then randomized to receive 3 MU (group I, n = 37) or 9 MU (group II, n = 39) for 48 weeks. Of the RNA-positive patients, only those with normal ALT received another 9 MU 48-week treatment (group III, n = 45). Sustained responders (SR) were defined as those with negative RNA and normal ALT 6 months after the therapy. SR rates based on intent-to-treat principle did not differ significantly between groups I and II (30% vs 41%), but those based on the protocol-compatible cases showed a significantly lower than those in group II. Adverse effects of IFN, developed more frequently in groups II and III than in group I, were mostly reversible. In conclusion, our results encourage 9 MU 60-week IFN alpha treatment in HCV/1b-infected patients with careful attention to adverse effects, and suggest that the treatment should be discontinued if HCV RNA does not disappear within 12 weeks.
13 schema:genre research_article
14 schema:inLanguage en
15 schema:isAccessibleForFree false
16 schema:isPartOf N8ce063bde558488aa993e57073b2f72c
17 N9c681ae8992b401eae6f90070a004380
18 sg:journal.1083335
19 schema:name High-dose (9 MU) long-term (60 weeks) alfa-interferon therapy for chronic hepatitis patients infected with HCV genotype 1b
20 schema:pagination 1545-1554
21 schema:productId N2a6cc800f217429da8fe632610b4ace5
22 N6384a9d2e61647c19924dc53a619cfbc
23 Nb906721d59d3456c9b5689975d92ae34
24 Nc844c0fdd2754f0190318e85d7dcb95c
25 Ne29bba9a58fb4d50b416070a9deafa82
26 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034445880
27 https://doi.org/10.1007/s007050050397
28 schema:sdDatePublished 2019-04-10T16:34
29 schema:sdLicense https://scigraph.springernature.com/explorer/license/
30 schema:sdPublisher N3a0bf4366ca64e17808441761cd14b1e
31 schema:url http://link.springer.com/10.1007/s007050050397
32 sgo:license sg:explorer/license/
33 sgo:sdDataset articles
34 rdf:type schema:ScholarlyArticle
35 N03a81c8441214ab6bde8ceafceda7ebe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
36 schema:name Hepacivirus
37 rdf:type schema:DefinedTerm
38 N2917f37751a64fb5bd5a18cab534bb61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
39 schema:name Hepatitis C, Chronic
40 rdf:type schema:DefinedTerm
41 N2a6cc800f217429da8fe632610b4ace5 schema:name nlm_unique_id
42 schema:value 7506870
43 rdf:type schema:PropertyValue
44 N2d97981bb3d747f0b4fcf08fa2089a1e rdf:first sg:person.0770416306.49
45 rdf:rest Nfeae65dd5c3a40819dbc957961050e8c
46 N3191d4a0035d4bf4b8461eeef6a85388 rdf:first sg:person.013711476524.52
47 rdf:rest rdf:nil
48 N3a0bf4366ca64e17808441761cd14b1e schema:name Springer Nature - SN SciGraph project
49 rdf:type schema:Organization
50 N3abfa2db44044c80ab52d3ab08e81e1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
51 schema:name Genotype
52 rdf:type schema:DefinedTerm
53 N3d47ae7ed8d4491ca6113fa58ea4c980 schema:name Department of Medicine, Aikawa Internal Hospital, Ibaraki, Japan, Japan
54 rdf:type schema:Organization
55 N4b714ea0fce2478fa71e156a51f49ea1 rdf:first sg:person.01261704052.37
56 rdf:rest N75db0dab4fb64b738f74a55b1400ab21
57 N5e444595e21042eaae4f391f41e5d95a schema:name Department of Medicine, Kojima Internal Clinic, Gifu, Japan, Japan
58 rdf:type schema:Organization
59 N6384a9d2e61647c19924dc53a619cfbc schema:name doi
60 schema:value 10.1007/s007050050397
61 rdf:type schema:PropertyValue
62 N7522fdb732d94b2988c474f222186067 rdf:first sg:person.0674453736.53
63 rdf:rest N3191d4a0035d4bf4b8461eeef6a85388
64 N75db0dab4fb64b738f74a55b1400ab21 rdf:first sg:person.011276771725.14
65 rdf:rest N82729c90912741259d69b2487eed96fc
66 N7f2eeea7520248da808e7f46348424d9 rdf:first sg:person.01330017252.58
67 rdf:rest Nd8ffe95937b948ffaeb0cf5a3e7c0b12
68 N82729c90912741259d69b2487eed96fc rdf:first sg:person.011764702202.27
69 rdf:rest Nc6fc028c125741a48a9452dbfd525f7a
70 N8ce063bde558488aa993e57073b2f72c schema:issueNumber 8
71 rdf:type schema:PublicationIssue
72 N9c681ae8992b401eae6f90070a004380 schema:volumeNumber 143
73 rdf:type schema:PublicationVolume
74 Nb545b0a14e2d49b79b9b358ffbf6c42f rdf:first sg:person.01055662424.90
75 rdf:rest N7522fdb732d94b2988c474f222186067
76 Nb906721d59d3456c9b5689975d92ae34 schema:name dimensions_id
77 schema:value pub.1034445880
78 rdf:type schema:PropertyValue
79 Nbb41b7c54b484ef089d3e59f00ac9231 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Recombinant Proteins
81 rdf:type schema:DefinedTerm
82 Nc6fc028c125741a48a9452dbfd525f7a rdf:first sg:person.01001517660.10
83 rdf:rest Nb545b0a14e2d49b79b9b358ffbf6c42f
84 Nc844c0fdd2754f0190318e85d7dcb95c schema:name pubmed_id
85 schema:value 9739333
86 rdf:type schema:PropertyValue
87 Nd8ffe95937b948ffaeb0cf5a3e7c0b12 rdf:first sg:person.01022667506.79
88 rdf:rest N2d97981bb3d747f0b4fcf08fa2089a1e
89 Nd99505f363294c8eb0c47e7b472bcedd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Interferon-alpha
91 rdf:type schema:DefinedTerm
92 Ne29bba9a58fb4d50b416070a9deafa82 schema:name readcube_id
93 schema:value a41617b0d107430aefb554723cb452d58c0cf58ade50634fca97647d61a55210
94 rdf:type schema:PropertyValue
95 Nfb94f82b1e464e88ab072f6390624cf2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Humans
97 rdf:type schema:DefinedTerm
98 Nfeae65dd5c3a40819dbc957961050e8c rdf:first sg:person.01106573463.58
99 rdf:rest N4b714ea0fce2478fa71e156a51f49ea1
100 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
101 schema:name Medical and Health Sciences
102 rdf:type schema:DefinedTerm
103 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
104 schema:name Clinical Sciences
105 rdf:type schema:DefinedTerm
106 sg:journal.1083335 schema:issn 0304-8608
107 1432-8798
108 schema:name Archives of Virology
109 rdf:type schema:Periodical
110 sg:person.01001517660.10 schema:affiliation https://www.grid.ac/institutes/grid.411951.9
111 schema:familyName Kawasaki
112 schema:givenName T.
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001517660.10
114 rdf:type schema:Person
115 sg:person.01022667506.79 schema:affiliation https://www.grid.ac/institutes/grid.264706.1
116 schema:familyName Kako
117 schema:givenName M.
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022667506.79
119 rdf:type schema:Person
120 sg:person.01055662424.90 schema:affiliation https://www.grid.ac/institutes/grid.411951.9
121 schema:familyName Nakashima
122 schema:givenName M.
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055662424.90
124 rdf:type schema:Person
125 sg:person.01106573463.58 schema:affiliation https://www.grid.ac/institutes/grid.410849.0
126 schema:familyName Tsubouchi
127 schema:givenName H.
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106573463.58
129 rdf:type schema:Person
130 sg:person.011276771725.14 schema:affiliation N5e444595e21042eaae4f391f41e5d95a
131 schema:familyName Kojima
132 schema:givenName M.
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011276771725.14
134 rdf:type schema:Person
135 sg:person.011764702202.27 schema:affiliation https://www.grid.ac/institutes/grid.417136.6
136 schema:familyName Harada
137 schema:givenName H.
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011764702202.27
139 rdf:type schema:Person
140 sg:person.01261704052.37 schema:affiliation N3d47ae7ed8d4491ca6113fa58ea4c980
141 schema:familyName Aikawa
142 schema:givenName T.
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261704052.37
144 rdf:type schema:Person
145 sg:person.01330017252.58 schema:affiliation https://www.grid.ac/institutes/grid.417200.0
146 schema:familyName Kanai
147 schema:givenName K.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330017252.58
149 rdf:type schema:Person
150 sg:person.013711476524.52 schema:affiliation https://www.grid.ac/institutes/grid.417200.0
151 schema:familyName Mishiro
152 schema:givenName S.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013711476524.52
154 rdf:type schema:Person
155 sg:person.0674453736.53 schema:affiliation https://www.grid.ac/institutes/grid.410804.9
156 schema:familyName Okamoto
157 schema:givenName H.
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674453736.53
159 rdf:type schema:Person
160 sg:person.0770416306.49 schema:affiliation https://www.grid.ac/institutes/grid.416762.0
161 schema:familyName Kumada
162 schema:givenName T.
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770416306.49
164 rdf:type schema:Person
165 https://www.grid.ac/institutes/grid.264706.1 schema:alternateName Teikyo University
166 schema:name The Fourth Department of Medicine, Teikyo University School of Medicine, Mizonokuchi Hospital, Kanagawa, Japan, Japan
167 rdf:type schema:Organization
168 https://www.grid.ac/institutes/grid.410804.9 schema:alternateName Jichi Medical University
169 schema:name Immunology Division, Jichi Medical School, Tochigi, Japan, Japan
170 rdf:type schema:Organization
171 https://www.grid.ac/institutes/grid.410849.0 schema:alternateName University of Miyazaki
172 schema:name The Second Department of Medicine, Miyazaki Medical College, Miyazaki, Japan, Japan
173 rdf:type schema:Organization
174 https://www.grid.ac/institutes/grid.411951.9 schema:alternateName Hamamatsu University
175 schema:name Department of Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Japan, Japan
176 The Second Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan, Japan
177 rdf:type schema:Organization
178 https://www.grid.ac/institutes/grid.416762.0 schema:alternateName Ogaki Municipal Hospital
179 schema:name Department of Gastroenterology, Ogaki Municipal Hospital, Gifu, Japan, Japan
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.417136.6 schema:alternateName Tokyo National Hospital
182 schema:name Department of Medicine, Tokyo National Chest Hospital, Tokyo, Japan, Japan
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.417200.0 schema:alternateName Toshiba General Hospital
185 schema:name Department of Gastroenterology, Toshiba General Hospital, Tokyo, Japan, Japan
186 Department of Medical Sciences, Toshiba General Hospital, Tokyo, Japan, Japan
187 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...